Hereditary non-polyposis colorectal cancer is predicted to contribute towards colorectal cancer in young South African blacks

South African Journal of Science

Volumn 105, Issue 1-2, 2009, Pages 68-72

  Cronje, L ^a   Becker, P J ^b   Paterson, A C ^a   Ramsay, M ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Colorectal neoplasms; Hereditary cancer syndromes

Indexed keywords

BLACK POPULATION; CANCER; HEALTH RISK; HERITABILITY; METHYLATION; MOLECULAR ANALYSIS; MUTATION; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; TUMOR;

AFRICA; SOUTH AFRICA; SOUTHERN AFRICA; SUB-SAHARAN AFRICA;

EID: 67149131843     PISSN: 00382353     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0038-23532009000100023     Document Type: Article

References (23)

1. Hamilton S.R., Vogelstein B., Kudo S., Riboli E., Nakamura S. and Hainout P. (2000). Tumours of the colon and rectum. In Pathology and Genetics of Tumours of the Digestive System, eds S.R. Hamilton and L.A. Aaltonen, pp. 103-129. IARC Press, iyon.
2. Bright-Thomas R.M. and Hargest R. (2003). APC, 0-catenin and hTCF-4; an unholytrinityinthegenesisofcolorectalcancetEur.J. Surg. Oncol. 29, 107-117.
3. Fearnhead N.S., Britton M.P. and Bodmer WE (2001). The ABC of APC. Hum. Mol Genet. 10, 721-733.
4. Raut C.P., Pawlik T.M. and Rodriquez-Bigas M. (2004). Clinicopathologic features in colorectal cancer patients with microsatellite instability. Mutat. Res. 568, 275-282.
5. Boland C.R., Thibodeau S.N., Hamilton S.R., Sidransky D., Eshleman J.R., Butt R.W., Meltzer S.J., Rodriques-Bigas M.A., Fodde R., Ranzani G.N. and Srivastava S. (1998). A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58, 5248-5257.
6. Peltomaki P. and de la ChapeUe A. (1997). Mutations predisposing to hereditary nonpolyposis colorectal cancer database and results of a collaborative study. Gastraenterol. 113, 1146-1158.
7. Jass J.R., Walsh M.D., Barker M., Simms L.A., Young J. and Legget B.A. (2002). Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability. Eur.J. Cancer 38, 858-866.
8. Cronje L., Paterson A.C. and Becker PJ. (2009). Colorectal cancer in South Africa: a heritable cause suspected in many young black patients. S. Afr. Med. J. 99, 103-106.
9. Boytechev H., Markovic S. and Oettle GJ. (1999). The characteristics of large bowel cancer in the low-risk black population of the Witwatersrand.J. R. Coll. Surg. Edinb. 44, 366-370.
10. Toyota M., Ahuja N., Ohe-Toyota M., Herman J.G., Baylin S.B. and Issa J.P. (1999). CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acai. Sri. U.S.A. 96, 8681-8686.
11. Xing M. (2005). BRAF mutation in thyroid cancer. Endocr. Relat. Cancer. 12, 245-262.
12. Lord R.VN., O'Grady R., Sheehan C, Field A.F. and Ward R.L. (2000). K-ras codon 12 mutations in Barrett's oesophagus and adenocardnomas of the oesophagus oesophagogastric junction.J. Gastroenterol. Hepatol. 15, 730-736.
13. Umar A., Boland C.R., Terdiman J.P., Syngal S., de la Chapelle A., Ruschoff J., Fishel R., Lindor N.M., Burgart L.J., Hametin R., Halimton S.R., Hiatt R.A., Jass J., Lindblom A., Lynch H.T, Peltomaki P., Ramsey S.D., Rodriquez-Bigas M.A., Vasen H.F., Hawk E.T., Barret J.C., Freedman A.N. and Srivastava S. (2004). Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.J. Natl. Cancer. Inst. 96, 261-268.
14. Grady W.M. (2003). Genetic testing for high-risk colon cancer patients. Gastroenterol. 124, 1574-1594.
15. Lynch H.T. and de la Chapelle A. (2003). Hereditary colorectal cancer. N. Engl. J. Med. 348, 919-932.
16. Rowley P.T (2005). Inherited susceptibility to colorectal cancer. Annu. Rev. Med. 56, 554.
17. Chan A.O., Issa J.P.H., Morris J.S., Hamilton S.R. and Rashid A. (2002). Concordant CpG island methylation in hyperplastic polyposis. Am. J. Pathol. 160, 529-536.
18. Kim I.J., Kang H.C., Jang S.G., Kim K., Ann S.A., Yoon H.J., Yoon S.N. and Park J.G. (2006). Oligonucleotide microarray analysis of distinct gene expression patterns in colorectal cancer tissues harboring BRAF and K-ras mutations. Carcinogenesis 27, 392-404.
19. Deng G., Chen A., Hong J., Chae H.S. and Kim Y.S. (1999). Methylation of CpG in a small region of the hMLHl promoter invariably correlates with the absence of gene expression. Cancer. Res. 59, 2029-2033.
20. Domingo E., Laiho P., OUikainen M., Pinto M., Wang L., French A.J., Westra J., Frebourg T, Espin E., Armengol M., Hamelin R., Yamamoto H., Hofstra R.M., Seruca R., Lindblom A., Peltomaki P., Thibodeau S.N., Aaltonen L.A. and Schwartz S. (2004). BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.J. Med. Genet. 41, 664-668.
21. Oliveira C, Westra J.L., Arango D., OUikainen M., Domingo E., Ferreira A., Velho S., Niessen R., Lagerstedt K., Alhopuro P., Laiho P., Veiga I., Teixeira M.R., Ligtenberg M., Kleibeuker J.H., Sijmons R.H., Plukker J.T, Imai K., Lage P., Hamelin R., Albuquerque C, Schwartz S., Lindblom A., Peltomaki P., Yamamoto H., Aaltonen L.A., Seruca R. and Hofstra R.M. (2004). Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLHl methylation status. Hum. Mol. Genet. 13, 2303-2311.
22. Jass J.R., Biden KG., Cummings M.C., Simms L.A., Walsh M., Schoch E., Meltzer S.J., Wright C, Searle J., Young J. and Legget B.A. (1999). Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J. Clin. Pathol. 52, 455-460.
23. Giardiello F.M.,Brensinger J.D. and Petersen G.M. (2001). AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterol. 121, 198-213.